Antimicrobial Resistance: Implications and Costs

References

• Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS One. 2017;12:e0189621. doi:10.1371/journal.pone.018962129267306
   PubMed Web of Science ®Google Scholar
• Antibiotic resistance: a global threat | features | CDC. https://www.cdc.gov/features/antibiotic-resistance-global/index.html. Accessed 915, 2019.
   Google Scholar
• Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309. doi:10.1179/2047773215Y.000000003026343252
   PubMed Web of Science ®Google Scholar
• Chokshi A, Sifri Z, Cennimo D, Horng H. Global Contributors to Antibiotic Resistance. J Glob Infect Dis. 2019;11(1):36–42. doi:10.4103/jgid.jgid_110_1830814834
   PubMed Web of Science ®Google Scholar
• ECDC. Surveillance of Antimicrobial Resistance in Europe. 2017 Available from: https://www.ecdc.europa.eu/sites/default/files/documents/EARS-Net-report-2017-update-jan-2019.pdf. Accessed September 16, 2019.
   Google Scholar
• Shrestha P, Cooper BS, Coast J, et al. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrob Resist Infect Control. 2018;7(1):98. doi:10.1186/s13756-018-0384-330116525
   PubMedGoogle Scholar
• Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241. doi:10.1177/204209861455491925436105
   PubMedGoogle Scholar
• Antibiotic resistance threats in the United States; 2013 https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed 916, 2019.
   Google Scholar
• WHO library cataloguing-in-publication data global action plan on antimicrobial resistance; 2015 www.paprika-annecy.com. Accessed 916, 2019.
   Google Scholar
• Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of infections due to MDR gram-negative bacteria. Front Med. 2019;6:74. doi:10.3389/fmed.2019.00074
   PubMed Web of Science ®Google Scholar
• Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJ, Márquez-Díaz F, Harel J, Guerrero-Barrera AL. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob. 2018;17(1):34. doi:10.1186/s12941-018-0286-530041652
   PubMed Web of Science ®Google Scholar
• Annavajhala MK, Gomez-Simmonds A, Uhlemann A-C. Multidrug-resistant enterobacter cloacae complex emerging as a global, diversifying threat. Front Microbiol. 2019;10:44. doi:10.3389/fmicb.2019.0004430766518
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Poonawala H, Jain Y. Drug-resistant tuberculosis: is India ready for the challenge? Commentary. BMJ Glob Heal. 2018;3:971. doi:10.1136/bmjgh-2018-000971
   Google Scholar
• Friedrich MJ. Drug-resistant tuberculosis predicted to increase in high-burden countries. JAMA. 2017;318(3):231. doi:10.1001/jama.2017.9086
   Web of Science ®Google Scholar
• Bin ZS, Hussain MA, Nye R, Mehta V, Mamun KT, Hossain N. A review on antibiotic resistance: alarm bells are ringing. Cureus. 2017;9(6):e1403. doi:10.7759/cureus.140328852600
   PubMedGoogle Scholar
• Langford BJ, Morris AM. Is it time to stop counselling patients to “finish the course of antibiotics”? Can Pharm J (Ott). 2017;150(6):349–350. doi:10.1177/171516351773554929123590
   PubMedGoogle Scholar
• Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277–283.25859123
   PubMedGoogle Scholar
• Chaw PS, Höpner J, Mikolajczyk R. The knowledge, attitude and practice of health practitioners towards antibiotic prescribing and resistance in developing countries—A systematic review. J Clin Pharm Ther. 2018;43(5):606–613. doi:10.1111/jcpt.1273029959783
   PubMed Web of Science ®Google Scholar
• Van Nguyen K, Do NT T, Chandna A, et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health. 2013;13:1158. doi:10.1186/1471-2458-13-115824325208
   PubMed Web of Science ®Google Scholar
• Spellberg B. The maturing antibiotic mantra: “Shorter is still better”. J Hosp Med. 2018;13(5):361–362. doi:10.12788/jhm.290429370317
   PubMedGoogle Scholar
• Laxminarayan R. Antibiotic effectiveness: balancing conservation against innovation. Science. 2014;345(6202):1299–1301. doi:10.1126/science.125416325214620
   PubMedGoogle Scholar
• Tang Q, Song P, Li J, Kong F, Sun L, Xu L. Control of antibiotic resistance in China must not be delayed: the current state of resistance and policy suggestions for the government, medical facilities, and patients. Biosci Trends. 2016;10(1):1–6. doi:10.5582/bst.2016.0103426961210
   PubMed Web of Science ®Google Scholar
• Fletcher-Lartey S, Yee M, Gaarslev C, Khan R. Why do general practitioners prescribe antibiotics for upper respiratory tract infections to meet patient expectations: a mixed methods study. BMJ Open. 2016;6(10):e012244. doi:10.1136/bmjopen-2016-012244
   PubMed Web of Science ®Google Scholar
• Dempsey PP, Businger AC, Whaley LE, Gagne JJ, Linder JA. Primary care clinicians’ perceptions about antibiotic prescribing for acute bronchitis: a qualitative study. BMC Fam Pract. 2014;15(1):194. doi:10.1186/s12875-014-0194-525495918
   PubMedGoogle Scholar
• Chang Q, Wang W, Regev-Yochay G, Lipsitch M, Hanage WP. Antibiotics in agriculture and the risk to human health: how worried should we be? Evol Appl. 2015;8(3):240–247. doi:10.1111/eva.1218525861382
   PubMed Web of Science ®Google Scholar
• Animal production | antimicrobial resistance | food and agriculture organization of the United Nations. http://www.fao.org/antimicrobial-resistance/key-sectors/animal-production/en/. Accessed 916, 2019.
   Google Scholar
• Bartlett JG, Gilbert DN, Spellberg B. Seven ways to preserve the miracle of antibiotics. Clin Infect Dis. 2013;56(10):1445–1450. doi:10.1093/cid/cit07023403172
   PubMed Web of Science ®Google Scholar
• Drug-resistant infections a threat to our economic future; 2017 Available from: www.worldbank.org. Accessed 916, 2019.
   Google Scholar
• Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science. 2016;352(6285):544–545. doi:10.1126/science.aad935827126037
   PubMed Web of Science ®Google Scholar
• Hao H, Cheng G, Iqbal Z, et al. Benefits and risks of antimicrobial use in food-producing animals. Front Microbiol. 2014;5:288. doi:10.3389/fmicb.2014.0028824971079
   PubMed Web of Science ®Google Scholar
• United Nations meeting on antimicrobial resistance. Bull World Health Organ. 2016;94(9):638–639. doi:10.2471/BLT.16.02091627708467
   PubMed Web of Science ®Google Scholar
• Lekagul A, Tangcharoensathien V, Yeung S. Patterns of antibiotic use in global pig production: a systematic review. Vet Anim Sci. 2019;7:100058. doi:10.1016/J.VAS.2019.100058
   PubMedGoogle Scholar
• Rhouma M, Beaudry F, Thériault W, Letellier A. Colistin in pig production: chemistry, mechanism of antibacterial action, microbial resistance emergence, and one health perspectives. Front Microbiol. 2016;7:1789. doi:10.3389/fmicb.2016.0178927891118
   PubMed Web of Science ®Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463–E3470. doi:10.1073/pnas.171729511529581252
   PubMed Web of Science ®Google Scholar
• Dall C. Global antibiotic use rises, fueled by economic growth | CIDRAP. Available from: http://www.cidrap.umn.edu/news-perspective/2018/03/global-antibiotic-use-rises-fueled-economic-growth. Accessed 916, 2019..
   Google Scholar
• Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci. 2015;112(18):5649–5654. doi:10.1073/pnas.150314111225792457
   PubMed Web of Science ®Google Scholar
• Robertson J, Iwamoto K, Hoxha I, et al. Antimicrobial medicines consumption in Eastern Europeand Central Asia – an updated cross-national study and assessment of quantitativemetrics for policy action. Front Pharmacol. 2019;9:1156. doi:10.3389/fphar.2018.0115630890943
   PubMed Web of Science ®Google Scholar
• Castro-Sánchez E, Moore LSP, Husson F, Holmes AH. What are the factors driving antimicrobial resistance? Perspectives from a public event in London, England. BMC Infect Dis. 2016;16(1):465. doi:10.1186/s12879-016-1810-x27590053
   PubMed Web of Science ®Google Scholar
• Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. Global geographic trends in antimicrobial resistance: the role of international travel. J Travel Med. 2019. doi:10.1093/jtm/taz036
   Google Scholar
• Ruppé E, Armand-Lefèvre L, Estellat C, et al. Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013. Eurosurveillance. 2014;19(14):20768. doi:10.2807/1560-7917.ES2014.19.14.2076824739981
   PubMed Web of Science ®Google Scholar
• Read AF, Woods RJ. Antibiotic resistance management. Evol Med Public Heal. 2014;2014(1):147. doi:10.1093/emph/eou024
   Google Scholar
• Li Q, Chang W, Zhang H, Hu D, Wang X. The role of plasmids in the multiple antibiotic resistance transfer in ESBLs-producing escherichia coli isolated from wastewater treatment plants. Front Microbiol. 2019;10:633. doi:10.3389/fmicb.2019.0063331001218
   PubMed Web of Science ®Google Scholar
• Rozwandowicz M, Brouwer MSM, Fischer J, et al. Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrob Chemother. 2018;73(5):1121–1137. doi:10.1093/jac/dkx48829370371
   PubMed Web of Science ®Google Scholar
• San Millan A. Evolution of plasmid-mediated antibiotic resistance in the clinical context. Trends Microbiol. 2018;26(12):978–985. doi:10.1016/j.tim.2018.06.00730049587
   PubMed Web of Science ®Google Scholar
• Sun D, Jeannot K, Xiao Y, Knapp CW. Editorial: horizontal gene transfer mediated bacterial antibiotic resistance. Front Microbiol. 2019;10. doi:10.3389/FMICB.2019.01933
   Web of Science ®Google Scholar
• Paterson IK, Hoyle A, Ochoa G, Baker-Austin C, Taylor NGH. Optimising antibiotic usage to treat bacterial infections. Sci Rep. 2016;6(1):37853. doi:10.1038/srep3785327892497
   PubMedGoogle Scholar
• Antibiotic resistance: a global threat | features | CDC. Available from: https://www.cdc.gov/features/antibiotic-resistance-global/index.html. Accessed 916, 2019.
   Google Scholar
• AMR in the WHO European Region. 9 2019 Available from: http://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/about-amr/amr-in-the-who-european-region. Accessed 9 16, 2019.
   Google Scholar
• Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–1658. doi:10.2147/IDR.S17386730349322
   PubMed Web of Science ®Google Scholar
• Carter RR, Sun J, Jump RLP. A survey and analysis of the american public’s perceptions and knowledge about antibiotic resistance. Open Forum Infect Dis. 2016;3(3):ofw112. doi:10.1093/ofid/ofw11227382598
   PubMed Web of Science ®Google Scholar
• Atif M, Asghar S, Mushtaq I, et al. What drives inappropriate use of antibiotics? A mixed methods study from Bahawalpur, Pakistan. Infect Drug Resist. 2019;12:687–699. doi:10.2147/IDR.S18911430988635
   PubMed Web of Science ®Google Scholar
• Almohammed RA, Bird EL. Public knowledge and behaviours relating to antibiotic use in gulf cooperation council countries: a systematic review. J Infect Public Health. 2019;12(2):159–166. doi:10.1016/j.jiph.2018.09.00230245158
   PubMed Web of Science ®Google Scholar
• Kamata K, Tokuda Y, Gu Y, Ohmagari N, Yanagihara K. Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: a national questionnaire survey in 2017. Angelillo IF, ed. PLoS One. 2018;13(11):e0207017. doi:10.1371/journal.pone.020701730395640
   PubMedGoogle Scholar
• Cecchini M, Langer J, Slawomirski L Antimicrobial Resistance In G7 Countries And Beyond: economic issues, policies and options for action; 2015 Available from: https://www.oecd.org/els/health-systems/Antimicrobial-Resistance-in-G7-Countries-and-Beyond.pdf. Accessed 916, 2019..
   Google Scholar
• Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22(5):416–422. doi:10.1016/j.cmi.2015.12.00226706614
   PubMed Web of Science ®Google Scholar
• Tackling drug-resistant infections globally: final report and recommendations the review on antimicrobial resistance chaired by JIM O’NEILL; 2016 Available from: https://amr-review.org/sites/default/files/160518_Final paper_with cover.pdf. Accessed 916, 2019.
   Google Scholar
• Davis M, Liu T-L, Taylor Y, et al. Exploring patient awareness and perceptions of the appropriate use of antibiotics: a mixed-methods study. Antibiotics. 2017;6(4):23. doi:10.3390/antibiotics6040023
   Web of Science ®Google Scholar
• WHO report on surveillance of antibiotic consumption; 2016 https://www.who.int/medicines/areas/rational_use/who-amr-amc-report-20181109.pdf. Accessed 917, 2019.
   Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi:10.1016/S1473-3099(13)70318-924252483
   PubMed Web of Science ®Google Scholar
• Jasovský D, Littmann J, Zorzet A, Cars O. Antimicrobial resistance-a threat to the world’s sustainable development. Ups J Med Sci. 2016;121(3):159–164. doi:10.1080/03009734.2016.119590027416324
   PubMed Web of Science ®Google Scholar
• Llibre JM. Time to get serious with HIV-1 resistance in sub-Saharan Africa. Lancet Infect Dis. 2017;17(3):241–243. doi:10.1016/S1473-3099(16)30447-927914855
   PubMedGoogle Scholar
• Pinoges L, Schramm B, Poulet E, et al. Risk factors and mortality associated with resistance to first-line antiretroviral therapy. JAIDS J Acquir Immune Defic Syndr. 2015;68(5):527–535. doi:10.1097/QAI.000000000000051325585301
   PubMed Web of Science ®Google Scholar
• HIV drug resistance report 2017 trends quality action. Available from: https://apps.who.int/iris/bitstream/handle/10665/255896/9789241512831-eng.pdf?sequence=1. Accessed 917, 2019.
   Google Scholar
• Phyo AP, Nosten F. The artemisinin resistance in Southeast Asia: an imminent global threat to malaria elimination. 2016. doi:10.5772/intechopen.76519
   Google Scholar
• World malaria report 2018 ISBN 978 92 4 156565 3. Available from: www.who.int/malaria. Accessed 917, 2019.
   Google Scholar
• Antimicrobial resistance: tackling a crisis for the health and wealth of nations. 2014. Available from: https://amr-review.org/sites/default/files/AMR Review Paper - Tackling a crisis for the health and wealth of nations_1.pdf. Accessed 917, 2019.
   Google Scholar
• Thorpe KE, Joski P, Johnston KJ. Antibiotic-resistant infection treatment costs have doubled since 2002, now exceeding $2 billion annually. Health Aff. 2018;37(4):662–669. doi:10.1377/hlthaff.2017.1153
   PubMed Web of Science ®Google Scholar
• Naylor NR, Atun R, Zhu N, et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018;7(1):58. doi:10.1186/s13756-018-0336-y29713465
   PubMed Web of Science ®Google Scholar
• Li B, Webster TJ. Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections. J Orthop Res. 2018;36(1):22–32. doi:10.1002/jor.2365628722231
   PubMed Web of Science ®Google Scholar
• Santoro-Lopes G, de Gouvêa EF. Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge. World J Gastroenterol. 2014;20(20):6201. doi:10.3748/wjg.v20.i20.620124876740
   PubMed Web of Science ®Google Scholar
• Anderson M, Clift C, Schulze K, et al. Health systems and policy analysis - Averting the AMR crisis : what are the avenues for policy. Eur Obs Heal Syst Policies. 2019.
   Google Scholar
• Utt E, Wells C. The global response to the threat of antimicrobial resistance and the important role of vaccines. Pharm Policy Law. 2016;18:179–197. doi:10.3233/PPL-160442
   Google Scholar
• Drug-resistant tuberculosis: worth the investment why drug-resistant tuberculosis? Available from: https://www.eiu.com/graphics/marketing/pdf/Drug-resistant-tuberculosis-Article.pdf. Accessed 917, 2019.
   Google Scholar
• Global pandemic | TB alliance. Available from: https://www.tballiance.org/why-new-tb-drugs/global-pandemic. Accessed 9 17, 2019.
   Google Scholar
• Taylor J, Hafner M, Yerushalmi E, et al. Estimating the economic costs of antimicrobial resistance: model and Results. 2005.
   Google Scholar
• Maddocks SE. Novel targets of antimicrobial therapies. Microbiol Spectr. 2016;4(2). doi:10.1128/microbiolspec.VMBF-0018-2015
   Web of Science ®Google Scholar
• CDC. National action plan for combating antibiotic-resistant bacteria; 2015 Available from: https://www.cdc.gov/drugresistance/pdf/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf. Accessed 930, 2019.
   Google Scholar
• Renwick MJ, Simpkin V, Mossialos E. Targeting Innovation in Antibiotic Drug Discovery and Development. European Observatory on Health Systems and Policies; 2016 Available from: http://www.ncbi.nlm.nih.gov/pubmed/28806044. Accessed 917, 2019.
   Google Scholar